医药生物行业周报 药辅行业迈入成熟期，关注医药辅料优 势企业 2026 年 03 月 02 日 【行情回顾】 【本周观点】 【风险提示】 医药行业政策风险；研发进展不及预期风险；业绩不及预期风险 挖掘价值 投资成长 强于大市（维持） 东方财富证券研究所 证券分析师：何玮 证书编号：S1160517110001 证券分析师：崔晓倩 证书编号：S1160525080001 相对指数表现 -10% -2% 6% 14% 22% 30% 2025/3 2025/9 2026/3 医药生物 沪深300 相关研究 《"小而美"药辅行业迎来产业升级》 2026.02.24 《ADC 商业化进程提速，本土创新药企多 路径布局产能》 2026.02.09 《《药品管理法实施条例》全面修订，推动 医药产业创新与监管升级》 2026.02.03 《医药零售高质量发展政策发布，行业有 望加速整合利好龙头》 2026.01.27 《J.P. Morgan 健康大会召开，中国创新药 企扬帆出海》 2026.01.20 行 业 研 究 / 医 药 生 物 / 证 券 研 究 报 告 本周(2026/02/23-2026/02/27，下同） ...

Group 1: Financial Performance - Gujing Gongjiu reported a net profit of 3.662 billion yuan for the first half of the year, an increase of 2.49% year-on-year, with operating revenue of 13.88 billion yuan, up 0.54% [1] - Guoxuan High-Tech announced a net profit of approximately 367 million yuan for the first half of 2025, a year-on-year increase of 35.22%, with operating revenue of about 19.394 billion yuan, up 15.48% [1] - Anhui Construction reported a net profit of approximately 553 million yuan for the first half of 2025, a decrease of 9.8% year-on-year, with operating revenue of about 30.185 billion yuan, down 9.79% [2] - Conch New Materials reported a net loss of approximately 29 million yuan for the first half of 2025, with operating revenue of about 2.401 billion yuan, down 9.7% year-on-year [6] Group 2: Corporate Actions - Zhongding Co., Ltd. signed a strategic cooperation agreement with the government of Hefei's Baohe District to establish a complete robot industry chain [3] - Anfu Technology's controlling shareholder, Qianhai Glory, decided to terminate its plan to continue increasing its stake in the company to avoid triggering mandatory tender offer obligations [5] - Yingjia Gongjiu plans to transfer 100% equity of Yingjia Business Hotel to Yingjia Guolv for 31.7265 million yuan as part of its asset optimization strategy [8] Group 3: Leadership Changes - Shanhe Pharmaceutical's controlling shareholder and chairman, Yin Zhenglong, passed away on August 26, 2025, holding approximately 63.0575 million shares, accounting for 26.9% of the company's total shares [7]